All Stories

  1. Filtering Instances and Rejecting Predictions to Obtain Reliable Models in Healthcare

    Article • Machine Learning, January 2026, Springer Science + Business Media

    Professor Carlos R V Kiffer

  2. Antimicrobial resistance burden estimates from the bottom-up: research priorities for estimating the impact of antimicrobial resistance in Brazil

    Article • IJID Regions, March 2025, Elsevier

    Professor Carlos R V Kiffer

  3. Understanding the performance of machine learning models from data- to patient-level

    Article • Journal of Data and Information Quality, September 2024, ACM (Association for Computing Machinery)

    Professor Carlos R V Kiffer, Ana Carolina Lorena

  4. Explaining instances in the health domain based on the exploration of a dataset's hardness embedding

    Article • July 2024, ACM (Association for Computing Machinery)

    Ana Carolina Lorena, Professor Carlos R V Kiffer

  5. A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence

    Article • Clinical Infectious Diseases, July 2023, Oxford University Press (OUP)

    Professor Carlos R V Kiffer

  6. The burden of inappropriate birth weight on neonatal survival in term newborns: a population-based study in a middle-income setting

    Article • Frontiers in Pediatrics, June 2023, Frontiers

    Professor Carlos R V Kiffer

  7. Temporal Trend, Causes, and Timing of Neonatal Mortality of Moderate and Late Preterm Infants in São Paulo State, Brazil: A Population-Based Study

    Article • Children, March 2023, MDPI AG

    Professor Carlos R V Kiffer

  8. NDM-producing Enterobacterales prevalence associated to COVID-19 in a tertiary hospital

    Article • The Brazilian Journal of Infectious Diseases, January 2023, Elsevier

    Professor Carlos R V Kiffer

  9. A Framework for Characterizing What Makes an Instance Hard to Classify

    Article • January 2023, Springer Science + Business Media

    Professor Carlos R V Kiffer

  10. Underreporting of unfavorable outcomes of congenital syphilis on the Notifiable Health Conditions Information System in the state of São Paulo, Brazil, 2007-2018

    Article • Epidemiologia e Serviços de Saúde, January 2023, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  11. Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa

    Article • Journal of Antimicrobial Chemotherapy, November 2022, Oxford University Press (OUP)

    Professor Carlos R V Kiffer

  12. Exploring the Bacteriome and Resistome of Humans and Food-Producing Animals in Brazil

    Article • Microbiology Spectrum, October 2022, ASM Journals

    Professor Carlos R V Kiffer

  13. Temporal Trend and Risk Factors for Respiratory Distress Syndrome–Associated Neonatal Mortality in Preterm Infants: A Population-Based Study in a Middle-Income Country

    Article • American Journal of Perinatology, August 2022, Thieme Publishing Group

    Professor Carlos R V Kiffer

  14. Large Scale Genome-Centric Metagenomic Data from the Gut Microbiome of Food-Producing Animals and Humans

    Article • Scientific Data, June 2022, Springer Science + Business Media

    Professor Carlos R V Kiffer

  15. Clusters of preterm live births and respiratory distress syndrome-associated neonatal deaths: spatial distribution and cooccurrence patterns

    Article • BMC Public Health, June 2022, Springer Science + Business Media

    Professor Carlos R V Kiffer

  16. Let the data speak: analysing data from multiple health centers of the São Paulo metropolitan area for COVID-19 clinical deterioration prediction

    Article • May 2022, Institute of Electrical & Electronics Engineers (IEEE)

    Professor Carlos R V Kiffer

  17. Broad-spectrum antimicrobial consumption trends and correlation with bacterial infections and antimicrobial resistance over 5 years

    Article • Journal of Global Antimicrobial Resistance, March 2022, Elsevier

    Professor Carlos R V Kiffer

  18. In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?

    Article • The Brazilian Journal of Infectious Diseases, March 2022, Elsevier

    Professor Carlos R V Kiffer

  19. Evaluation of high-concentration EDTA-modified carbapenemase inactivation method (eCIM) for SPM-producing Pseudomonas aeruginosa

    Article • Archives of Microbiology, December 2021, Springer Science + Business Media

    Professor Carlos R V Kiffer

  20. Using Machine Learning to support health system planning during the Covid-19 pandemic: a case study using data from São José dos Campos (Brazil)

    Article • CLEI electronic journal, December 2021, Centro Latino Americano de Estudios en Informatica

    Professor Carlos R V Kiffer

  21. Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-ResistantPseudomonas aeruginosaUsing the ERACE-PA Global Surveillance Program

    Article • Open Forum Infectious Diseases, December 2021, Oxford University Press (OUP)

    Professor Carlos R V Kiffer

  22. Bacterial infections in COVID-19 patients: a review

    Article • Revista da Associação Médica Brasileira, December 2021, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  23. Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization

    Article • Antimicrobial Agents and Chemotherapy, October 2021, ASM Journals

    Professor Carlos R V Kiffer

  24. Clusters of cause specific neonatal mortality and its association with per capita gross domestic product: A structured spatial analytical approach

    Article • PLOS One, August 2021, PLOS

    Professor Carlos R V Kiffer

  25. The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

    Article • European Journal of Clinical Microbiology & Infectious Diseases, July 2021, Springer Science + Business Media

    Professor Carlos R V Kiffer

  26. Operational Challenges in the Use of Structured Secondary Data for Health Research

    Article • Frontiers in Public Health, June 2021, Frontiers

    Professor Carlos R V Kiffer

  27. In vitro synergy of ticarcillin/clavulanate in combination with aztreonam and ceftolozane/tazobactam against SPM-1-producing Pseudomonas aeruginosa strains

    Article • Diagnostic Microbiology and Infectious Disease, June 2021, Elsevier

    Professor Carlos R V Kiffer

  28. Re: ‘Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes’ by Nutman et al.

    Article • Clinical Microbiology and Infection, March 2021, Elsevier

    Professor Carlos R V Kiffer

  29. Annual trend of neonatal mortality and its underlying causes: population-based study – São Paulo State, Brazil, 2004–2013

    Article • BMC Pediatrics, January 2021, Springer Science + Business Media

    Professor Carlos R V Kiffer

  30. In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa

    Article • Journal of Antimicrobial Chemotherapy, April 2020, Oxford University Press (OUP)

    Professor Carlos R V Kiffer

  31. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration

    Article • BMC Infectious Diseases, January 2020, Springer Science + Business Media

    Professor Carlos R V Kiffer

  32. Co-Occurrence of Respiratory Distress Syndrome-Associated Neonatal Mortality and Preterm Live Births: A Spatial Cluster Analysis

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Professor Carlos R V Kiffer

  33. Case report of a child with influenza and fatal community-associated methicillin-resistant Staphylococcus aureus sepsis

    Article • Revista da Sociedade Brasileira de Medicina Tropical, January 2020, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  34. Fulminant toxoplasmosis presenting as isolated myelitis

    Article • Arquivos de Neuro-Psiquiatria, December 2019, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  35. Prevalence of Human Papillomavirus (HPV) infection in women living in remote riverine communities in the Amazonas, Brazil

    Article • July 2019, Springer Science + Business Media

    Professor Carlos R V Kiffer

  36. A major monoclonal hospital outbreak of NDM-1–producing Klebsiella pneumoniae ST340 and the first report of ST2570 in Brazil

    Article • Infection Control and Hospital Epidemiology, February 2019, Cambridge University Press

    Professor Carlos R V Kiffer

  37. Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis

    Article • The Brazilian Journal of Infectious Diseases, January 2018, Elsevier

    Professor Carlos R V Kiffer

  38. Multi-state survey of healthcare-associated infections in acute care hospitals in Brazil

    Article • Journal of Hospital Infection, June 2017, Elsevier

    Professor Carlos R V Kiffer

  39. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics

    Article • International Journal of Antimicrobial Agents, May 2016, Elsevier

    Professor Carlos R V Kiffer

  40. Structure for prevention of health care–associated infections in Brazilian hospitals: A countrywide study

    Article • American Journal of Infection Control, January 2016, Elsevier

    Professor Carlos R V Kiffer

  41. A space–time model for carbapenemase-producing Klebsiella pneumoniae (KPC) cluster quantification in a high-complexity hospital

    Article • Epidemiology and Infection, January 2015, Cambridge University Press

    Professor Carlos R V Kiffer

  42. Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract

    Article • The Brazilian Journal of Infectious Diseases, September 2014, Elsevier

    Professor Carlos R V Kiffer

  43. Recommendations for the treatment of osteomyelitis

    Article • The Brazilian Journal of Infectious Diseases, September 2014, Elsevier

    Professor Carlos R V Kiffer

  44. Proposta sobre uso de dados de receitas de antimicrobianos retidas: a experiência EUREQA

    Article • Cadernos de Saúde Pública, May 2012, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  45. Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens

    Article • BMC Infectious Diseases, October 2011, Springer Science + Business Media

    Professor Carlos R V Kiffer

  46. Spatial exploration of Streptococcus pneumoniae clonal clustering in São Paulo, Brazil

    Article • Brazilian Journal of Infectious Diseases, October 2011, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  47. Spatial exploration of Streptococcus pneumoniae clonal clustering in São Paulo, Brazil

    Article • The Brazilian Journal of Infectious Diseases, September 2011, Elsevier

    Professor Carlos R V Kiffer

  48. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil

    Article • International Journal of Health Geographics, February 2011, Springer Science + Business Media

    Professor Carlos R V Kiffer

  49. Involvement of pmrAB and phoPQ in Polymyxin B Adaptation and Inducible Resistance in Non-Cystic Fibrosis Clinical Isolates of Pseudomonas aeruginosa

    Article • Antimicrobial Agents and Chemotherapy, July 2009, ASM Journals

    Dr Robert E Hancock, Professor Carlos R V Kiffer

  50. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil

    Article • Clinical Microbiology and Infection, February 2008, Elsevier

    Professor Carlos R V Kiffer

  51. A pharmacodynamic strategy to optimize empirical antibiotic therapy for gram-negative bacteria in a Brazilian Intensive Care Unit

    Article • The Brazilian Journal of Infectious Diseases, April 2007, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  52. P565 Antimicrobial resistance comparisons amongst extendedspectrum β-lactamase producing Klebsiella spp. phenotypes collected from Brazilian hospitals in 2003 and 2006

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Carlos R V Kiffer

  53. P1375 Pharmacodynamic comparison of linezolid, teicoplanin, and vancomycin against clinical isolates of Staphylococcus aureus and coagulase negative staphylococci collected from hospitals in Brazil

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Carlos R V Kiffer

  54. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city

    Article • International braz j urol, February 2007, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  55. Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil

    Article • International Journal of Antimicrobial Agents, October 2006, Elsevier

    Professor Carlos R V Kiffer

  56. In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii

    Article • Diagnostic Microbiology and Infectious Disease, August 2005, Elsevier

    Professor Carlos R V Kiffer

  57. Pseudomonas aeruginosa clonal dissemination in Brazilian intensive care units

    Article • Enfermedades Infecciosas y Microbiología Clínica, July 2005, Elsevier

    Dr Sylvia C Leao, Professor Carlos R V Kiffer

  58. Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003

    Article • The Brazilian Journal of Infectious Diseases, June 2005, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  59. Antimicrobial susceptibility in intensive care units: MYSTIC Program Brazil 2002

    Article • The Brazilian Journal of Infectious Diseases, February 2005, FapUNIFESP (SciELO)

    Professor Carlos R V Kiffer

  60. Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens—a Brazilian perspective from the GLOBAL Surveillance Initiative 2001–2002

    Article • Clinical Microbiology and Infection, June 2004, Elsevier

    Professor Carlos R V Kiffer

  61. Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002

    Article • Diagnostic Microbiology and Infectious Disease, June 2004, Elsevier

    Professor Carlos R V Kiffer